Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis

Type 2 innate lymphoid cells (ILC2) potentiate immune responses, however, their role in mediating adaptive immunity in cancer has not been assessed. Here, we report that mice genetically lacking ILC2s have significantly increased tumour growth rates and conspicuously higher frequency of circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Saranchova, Iryna, Han, Jeffrey, Zaman, Rysa, Arora, Hitesh, Huang, Hui, Fenninger, Franz, Choi, Kyung Bok, Munro, Lonna, Pfeifer, Cheryl G., Welch, Ian, Takei, Fumio, Jefferies, Wilfred A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811448/
https://www.ncbi.nlm.nih.gov/pubmed/29440650
http://dx.doi.org/10.1038/s41598-018-20608-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811448/
https://www.ncbi.nlm.nih.gov/pubmed/29440650
http://dx.doi.org/10.1038/s41598-018-20608-6

Ejemplares similares